Rare diseases
Investigational molecules
Locations
Gewerbestrasse 14, 4123
Research activity includes acute myocardial infarction and recurrent ischemic risk, with interest in early symptom-driven intervention and outcomes in patients vulnerable to another cardiac event.
The cardiovascular portfolio centers on emergency cardiac care and prevention of further infarction in high-risk populations.
Viatris Innovation GmbH runs clinical trials in conditions such as Systemic lupus erythematosus, Acute myocardial infarction, Lupus nephritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
AustriaStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
BulgariaRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
BulgariaStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
